C57BL/6N-Atm1Brd Aldh1b1tm2a(EUCOMM)Wtsi/WtsiH

Status

Available to order

EMMA IDEM:09729
International strain nameC57BL/6N-Atm1Brd Aldh1b1tm2a(EUCOMM)Wtsi/WtsiH
Alternative nameEPD0537_4_A09
Strain typeTargeted Mutant Strains
Allele/Transgene symbolAldh1b1tm2a(EUCOMM)Wtsi
Gene/Transgene symbolAldh1b1
DisclaimerPlease note that for EUCOMM and KOMP-CSD mice supplied to the scientific community by INFRAFRONTIER/EMMA:
  1. We can not guarantee a null mutation for Knock-out first alleles (tm1a alleles, see http://www.mousephenotype.org/about-ikmc/targeting-strategies) as the critical exon has not been deleted.
  2. That the structure of the targeted mutation in the ES cells obtained from EUCOMM/KOMP to generate EUCOMM/KOMP mice is not verified by INFRAFRONTIER/EMMA. It is recommended that the recipient confirms the mutation structure.
  3. No check for determining the copy number of the targeting construct in ES cells obtained from EUCOMM/KOMP is done by INFRAFRONTIER/EMMA.
  4. The level of quality control before mice are released is to confirm the individual mouse genotype by short range PCR.

Information from provider

Provider Wellcome Trust Sanger Institute
Provider affiliationWellcome Trust Sanger Institute
Genetic informationThis mouse line originates from EUCOMM ES clone EPD0537_4_A09. For further details on the construction of this clone see the page at the IMPC portal.
Phenotypic informationPotential phenotyping data in the IMPC portal
ReferencesNone available

Information from EMMA

Archiving centreMary Lyon Centre at MRC Harwell, Oxford, United Kingdom

Disease and phenotype information

IMPC phenotypes (allele matching)
  • increased grip strength / IMPC
IMPC phenotypes (gene matching)
  • increased grip strength / IMPC
MGI phenotypes (gene matching)
  • hyperglycemia / MGI
  • increased glucagon secretion / MGI
  • increased insulin secretion / MGI
  • decreased insulin secretion / MGI
  • oxidative stress / MGI
  • abnormal pancreas development / MGI
  • abnormal calcium ion homeostasis / MGI
  • abnormal pancreatic islet morphology / MGI
  • impaired glucose tolerance / MGI
  • insulin resistance / MGI
  • homeostasis/metabolism phenotype / MGI
  • endocrine/exocrine gland phenotype / MGI
  • pancreatic islet hyperplasia / MGI
  • abnormal xenobiotic pharmacokinetics / MGI
  • increased pancreatic beta cell mass / MGI
  • abnormal pancreatic beta cell differentiation / MGI
  • increased pancreatic alpha cell number / MGI
  • increased pancreatic delta cell number / MGI
  • increased pancreatic beta cell proliferation / MGI
  • increased fasted circulating glucose level / MGI
  • increased pancreatic beta cell apoptosis / MGI
  • increased pancreatic islet cell apoptosis / MGI

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Genotyping protocol

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
MTA will be issued after an order has been submitted.

EMMA conditions
Legally binding conditions for the transfer

Other EMMA strains

Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).